June16 , 2026

    DSV Launches ‘Indy Wings’ Route to Strengthen Pharma Cold-Chain Connectivity

    Related

    Indian LNG Carrier ‘Disha’ Safely Navigates Strait of Hormuz, Heads for Dahej Port

    The Indian-flagged liquefied natural gas (LNG) carrier Disha has...

    India’s West Asia Exports Gain Momentum Through Oman Transit Route

    India’s exports to West Asia are receiving a significant...

    India’s Container Ports Climb to 6th Globally as Throughput Nears 24 Million TEUs

    India’s container port sector has witnessed significant growth over...

    JSW Infrastructure Eyes Bengal’s New Deep-Sea Port Project at Dadanpatrabar

    JSW Infrastructure, India’s second-largest private port operator and part...

    Share

    Global logistics company DSV has expanded its Air ThermoDirect network with the introduction of a new direct air cargo connection between Indianapolis and Luxembourg, known as “Indy Wings”, aimed at enhancing temperature-controlled logistics for the pharmaceutical and healthcare sectors.

    The new route strengthens cold-chain connectivity between Indianapolis—one of the fastest-growing life sciences and healthcare hubs in the United States—and Luxembourg, a major European pharmaceutical gateway. The service is designed to provide greater supply chain control, improved visibility, and faster movement of temperature-sensitive healthcare products across key global trade lanes.

    To mark the launch, DSV hosted customers, partners, industry stakeholders, and local officials at Indianapolis International Airport on 11 June. Attendees were given a behind-the-scenes look at the company’s dedicated aircraft operations and temperature-controlled healthcare facilities, highlighting how integrated logistics solutions support the safe transportation of critical pharmaceutical shipments.

    According to DSV, the direct connection reduces transit time in uncontrolled environments and streamlines handling processes, helping safeguard product integrity while improving operational reliability, cost efficiency, and sustainability performance.

    “The Indianapolis operations will play a pivotal role in enhancing end-to-end visibility and control across key pharma regions, helping ensure that life-saving therapies move with greater speed, reliability and integrity,” said Kenneth Källström, Executive Vice President and Global Head of Healthcare at DSV.

    The launch comes amid growing healthcare and biotechnology investments across the U.S. Midwest, where leading pharmaceutical and biotech companies are driving demand for advanced temperature-controlled logistics infrastructure. The new Indianapolis–Luxembourg route is expected to support this growth by providing a more predictable and scalable transportation solution for high-value healthcare products.

    spot_img